<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>Anxiolytics & Sedatives | Domain 9 | MasteryPage</title>
  <link rel="preconnect" href="https://fonts.googleapis.com">
  <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
  <link href="https://fonts.googleapis.com/css2?family=Instrument+Serif:ital@0;1&family=Inter:wght@300;400;500;600;700&display=swap" rel="stylesheet">
  <style>
    :root {
      --bg-primary: #09090b; --bg-secondary: #0f0f11; --bg-tertiary: #18181b; --bg-card: #1c1c1f;
      --text-primary: #fafafa; --text-secondary: #a1a1aa; --text-muted: #71717a;
      --accent: #ef4444; --accent-dim: rgba(239, 68, 68, 0.15);
      --border: rgba(255, 255, 255, 0.06); --gradient-gold: linear-gradient(135deg, #f59e0b 0%, #d97706 100%);
      --radius-sm: 8px; --radius-md: 12px; --radius-lg: 16px;
      --font-display: 'Instrument Serif', Georgia, serif; --font-body: 'Inter', -apple-system, sans-serif;
    }
    * { margin: 0; padding: 0; box-sizing: border-box; }
    body { font-family: var(--font-body); background: var(--bg-primary); color: var(--text-primary); line-height: 1.7; }
    .top-nav { position: fixed; top: 0; left: 0; right: 0; height: 72px; background: rgba(9, 9, 11, 0.95); backdrop-filter: blur(20px); border-bottom: 1px solid var(--border); z-index: 1000; display: flex; align-items: center; padding: 0 32px; }
    .nav-left { display: flex; align-items: center; gap: 24px; }
    .logo { display: flex; align-items: center; gap: 10px; text-decoration: none; }
    .logo-icon { width: 36px; height: 36px; background: var(--gradient-gold); border-radius: 10px; display: flex; align-items: center; justify-content: center; }
    .logo-icon svg { width: 20px; height: 20px; color: var(--bg-primary); }
    .logo-text { font-family: var(--font-display); font-size: 1.35rem; color: var(--text-primary); }
    .breadcrumb { display: flex; align-items: center; gap: 8px; font-size: 0.9rem; color: var(--text-muted); }
    .breadcrumb a { color: var(--text-secondary); text-decoration: none; }
    .breadcrumb a:hover { color: var(--accent); }
    .breadcrumb svg { width: 16px; height: 16px; }
    .content-wrapper { padding-top: 72px; display: flex; min-height: 100vh; }
    .sidebar { width: 280px; background: var(--bg-secondary); border-right: 1px solid var(--border); position: fixed; top: 72px; bottom: 0; overflow-y: auto; padding: 24px 0; }
    .sidebar-header { padding: 0 20px 16px; border-bottom: 1px solid var(--border); margin-bottom: 16px; }
    .sidebar-title { font-size: 0.75rem; text-transform: uppercase; letter-spacing: 0.1em; color: var(--text-muted); margin-bottom: 8px; }
    .domain-title { font-size: 1rem; font-weight: 600; color: var(--accent); }
    .chapter-list { list-style: none; }
    .chapter-item { border-bottom: 1px solid var(--border); }
    .chapter-link { display: flex; align-items: center; gap: 12px; padding: 14px 20px; color: var(--text-secondary); text-decoration: none; font-size: 0.9rem; transition: all 0.2s ease; }
    .chapter-link:hover { background: var(--bg-tertiary); color: var(--text-primary); }
    .chapter-link.active { background: var(--accent-dim); color: var(--accent); border-left: 3px solid var(--accent); }
    .chapter-number { width: 24px; height: 24px; border-radius: 50%; background: var(--bg-tertiary); display: flex; align-items: center; justify-content: center; font-size: 0.75rem; font-weight: 600; flex-shrink: 0; }
    .sidebar-section-label { padding: 12px 20px 6px; font-size: 0.7rem; text-transform: uppercase; letter-spacing: 0.08em; color: var(--accent); font-weight: 600; }
    .main-content { margin-left: 280px; flex: 1; padding: 48px 64px; max-width: 900px; }
    .chapter-header { margin-bottom: 48px; }
    .chapter-badge { display: inline-flex; align-items: center; gap: 8px; padding: 6px 12px; background: var(--bg-tertiary); border: 1px solid var(--border); border-radius: 20px; font-size: 0.8rem; color: var(--text-muted); margin-bottom: 16px; }
    h1 { font-family: var(--font-display); font-size: 2.5rem; margin-bottom: 16px; line-height: 1.2; }
    .chapter-meta { display: flex; gap: 24px; color: var(--text-muted); font-size: 0.9rem; }
    .coming-soon-container { display: flex; flex-direction: column; align-items: center; justify-content: center; padding: 80px 40px; text-align: center; }
    .coming-soon-icon { width: 80px; height: 80px; background: var(--accent-dim); border-radius: 50%; display: flex; align-items: center; justify-content: center; margin-bottom: 32px; }
    .coming-soon-icon svg { width: 40px; height: 40px; color: var(--accent); }
    .coming-soon-title { font-family: var(--font-display); font-size: 2rem; margin-bottom: 16px; color: var(--text-primary); }
    .coming-soon-text { color: var(--text-secondary); font-size: 1.1rem; max-width: 500px; margin-bottom: 32px; line-height: 1.8; }
    .coming-soon-note { background: var(--bg-card); border: 1px solid var(--border); border-radius: var(--radius-md); padding: 20px 24px; color: var(--text-muted); font-size: 0.9rem; }
    .nav-buttons { display: flex; justify-content: space-between; margin-top: 64px; padding-top: 32px; border-top: 1px solid var(--border); }
    .nav-btn { display: flex; align-items: center; gap: 12px; padding: 16px 24px; background: var(--bg-card); border: 1px solid var(--border); border-radius: var(--radius-md); text-decoration: none; color: var(--text-secondary); transition: all 0.2s ease; }
    .nav-btn:hover { border-color: var(--accent); color: var(--text-primary); }
    .nav-btn-label { font-size: 0.8rem; color: var(--text-muted); }
    .nav-btn-title { font-weight: 600; color: var(--text-primary); }
    .content-section { margin-bottom: 48px; }
    .content-section h2 { font-family: var(--font-display); font-size: 1.8rem; margin-bottom: 20px; padding-bottom: 12px; border-bottom: 1px solid var(--border); }
    .content-section h3 { font-size: 1.25rem; font-weight: 600; margin: 28px 0 12px; color: var(--text-primary); }
    .content-section h4 { font-size: 1.05rem; font-weight: 600; margin: 20px 0 8px; color: var(--text-secondary); }
    .content-section p { color: var(--text-secondary); margin-bottom: 16px; font-size: 0.95rem; }
    .content-section ul, .content-section ol { color: var(--text-secondary); margin: 0 0 16px 24px; font-size: 0.95rem; }
    .content-section li { margin-bottom: 6px; }
    .key-term { color: var(--accent); font-weight: 600; }
    .definition-box { background: var(--bg-card); border-left: 3px solid var(--accent); border-radius: 0 var(--radius-sm) var(--radius-sm) 0; padding: 16px 20px; margin: 16px 0; }
    .definition-box strong { color: var(--text-primary); }
    .definition-box p { margin-bottom: 0; }
    .example-box { background: rgba(245, 158, 11, 0.06); border-left: 3px solid #f59e0b; border-radius: 0 var(--radius-sm) var(--radius-sm) 0; padding: 16px 20px; margin: 16px 0; }
    .example-box strong { color: #f59e0b; }
    .example-box p { margin-bottom: 0; }
    .clinical-note { background: rgba(59, 130, 246, 0.08); border-left: 3px solid #3b82f6; border-radius: 0 var(--radius-sm) var(--radius-sm) 0; padding: 16px 20px; margin: 16px 0; }
    .clinical-note strong { color: #3b82f6; }
    .clinical-note p { margin-bottom: 0; }
    .citation { font-size: 0.85rem; color: var(--text-muted); font-style: italic; }
    table { width: 100%; border-collapse: collapse; margin: 16px 0; font-size: 0.9rem; }
    th { background: var(--bg-tertiary); color: var(--text-primary); padding: 10px 14px; text-align: left; border: 1px solid var(--border); font-weight: 600; }
    td { padding: 10px 14px; border: 1px solid var(--border); color: var(--text-secondary); }
    @media (max-width: 1024px) { .sidebar { display: none; } .main-content { margin-left: 0; padding: 32px 24px; } }
    .chapter-actions { display: flex; gap: 12px; margin-bottom: 32px; flex-wrap: wrap; }
    .action-btn { display: inline-flex; align-items: center; gap: 8px; padding: 10px 20px; border-radius: 8px; font-size: 0.85rem; font-weight: 500; text-decoration: none; transition: all 0.2s ease; }
    .flashcard-btn { background: var(--bg-tertiary); border: 1px solid var(--border-light); color: var(--text-secondary); }
    .flashcard-btn:hover { background: var(--bg-card); color: var(--text-primary); border-color: var(--accent); }
    .quiz-btn { background: var(--bg-tertiary); border: 1px solid var(--border-light); color: var(--text-secondary); }
    .quiz-btn:hover { background: var(--bg-card); color: var(--text-primary); border-color: var(--accent); }
    .mastery-btn { background: linear-gradient(135deg, #f59e0b 0%, #ef4444 100%); border: none; color: #fff; font-weight: 600; box-shadow: 0 2px 12px rgba(245, 158, 11, 0.3); }
    .mastery-btn:hover { box-shadow: 0 4px 20px rgba(245, 158, 11, 0.5); transform: translateY(-1px); }
    .upgrade-modal-overlay { display:none; position:fixed; top:0; left:0; right:0; bottom:0; background:rgba(0,0,0,0.7); z-index:1000; align-items:center; justify-content:center; }
    .upgrade-modal-overlay.visible { display:flex; }
    .upgrade-modal { background:var(--bg-card); border:1px solid var(--border); border-radius:var(--radius-lg,16px); padding:40px; max-width:420px; width:90%; text-align:center; }
    .upgrade-modal-icon { width:64px; height:64px; margin:0 auto 20px; background:linear-gradient(135deg,#f59e0b 0%,#ef4444 100%); border-radius:50%; display:flex; align-items:center; justify-content:center; }
    .upgrade-modal-icon svg { color:#fff; }
    .upgrade-modal h3 { font-size:1.25rem; margin-bottom:8px; color:var(--text-primary); }
    .upgrade-modal p { color:var(--text-secondary); margin-bottom:24px; font-size:0.9rem; line-height:1.6; }
    .upgrade-modal-actions { display:flex; gap:12px; }
    .upgrade-modal-actions a, .upgrade-modal-actions button { flex:1; padding:12px; border-radius:8px; font-size:0.85rem; font-weight:600; cursor:pointer; text-decoration:none; text-align:center; border:none; }
    .upgrade-modal .btn-dismiss { background:var(--bg-tertiary); color:var(--text-secondary); border:1px solid var(--border); }
    .upgrade-modal .btn-upgrade { background:linear-gradient(135deg,#f59e0b 0%,#ef4444 100%); color:#fff; }
  </style>
</head>
<body>
  <nav class="top-nav">
    <div class="nav-left">
      <a href="../../index.html" class="logo">
        <div class="logo-icon"><svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2.5"><path d="M12 2L2 7l10 5 10-5-10-5zM2 17l10 5 10-5M2 12l10 5 10-5"/></svg></div>
        <span class="logo-text">MasteryPage</span>
      </a>
      <div class="breadcrumb">
        <svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M9 18l6-6-6-6"/></svg>
        <a href="../../textbook.html">Textbook</a>
        <svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M9 18l6-6-6-6"/></svg>
        <a href="index.html">Domain 9</a>
        <svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M9 18l6-6-6-6"/></svg>
        <span>Anxiolytics & Sedatives</span>
      </div>
    </div>
  </nav>
  <div class="content-wrapper">
    <aside class="sidebar">
      <div class="sidebar-header">
        <div class="sidebar-title">Domain 9</div>
        <div class="domain-title">Psychopharmacology &amp; Ethics</div>
      </div>
      <ul class="chapter-list">
        <li class="chapter-item"><a href="index.html" class="chapter-link"><span class="chapter-number">0</span>Overview</a></li>
        <li class="sidebar-section-label">Part A: APA Ethics Code</li>
        <li class="chapter-item"><a href="ethics-overview.html" class="chapter-link"><span class="chapter-number">A0</span>Overview & Principles</a></li>
        <li class="chapter-item"><a href="resolving-ethical-issues.html" class="chapter-link"><span class="chapter-number">A1</span>Resolving Ethical Issues</a></li>
        <li class="chapter-item"><a href="competence.html" class="chapter-link"><span class="chapter-number">A2</span>Competence</a></li>
        <li class="chapter-item"><a href="human-relations.html" class="chapter-link"><span class="chapter-number">A3</span>Human Relations</a></li>
        <li class="chapter-item"><a href="privacy-confidentiality.html" class="chapter-link"><span class="chapter-number">A4</span>Privacy & Confidentiality</a></li>
        <li class="chapter-item"><a href="advertising.html" class="chapter-link"><span class="chapter-number">A5</span>Advertising</a></li>
        <li class="chapter-item"><a href="record-keeping-fees.html" class="chapter-link"><span class="chapter-number">A6</span>Record Keeping & Fees</a></li>
        <li class="chapter-item"><a href="education-training.html" class="chapter-link"><span class="chapter-number">A7</span>Education & Training</a></li>
        <li class="chapter-item"><a href="research-publication.html" class="chapter-link"><span class="chapter-number">A8</span>Research & Publication</a></li>
        <li class="chapter-item"><a href="assessment-ethics.html" class="chapter-link"><span class="chapter-number">A9</span>Assessment</a></li>
        <li class="chapter-item"><a href="therapy-ethics.html" class="chapter-link"><span class="chapter-number">A10</span>Therapy</a></li>
        <li class="sidebar-section-label">Part B: Psychopharmacology</li>
        <li class="chapter-item"><a href="pharma-foundations.html" class="chapter-link"><span class="chapter-number">B0</span>Pharmacological Foundations</a></li>
        <li class="chapter-item"><a href="antidepressants.html" class="chapter-link"><span class="chapter-number">B1</span>Antidepressants</a></li>
        <li class="chapter-item"><a href="antipsychotics.html" class="chapter-link"><span class="chapter-number">B2</span>Antipsychotics</a></li>
        <li class="chapter-item"><a href="anxiolytics-sedatives.html" class="chapter-link active"><span class="chapter-number">B3</span>Anxiolytics & Sedatives</a></li>
        <li class="chapter-item"><a href="mood-stabilizers.html" class="chapter-link"><span class="chapter-number">B4</span>Mood Stabilizers</a></li>
        <li class="chapter-item"><a href="stimulants-adhd.html" class="chapter-link"><span class="chapter-number">B5</span>Stimulants & ADHD Meds</a></li>
        <li class="sidebar-section-label">Appendix</li>
        <li class="chapter-item"><a href="professional-issues.html" class="chapter-link"><span class="chapter-number">+</span>Professional Issues</a></li>
      </ul>
    </aside>
    <main class="main-content">
      <header class="chapter-header">
        <div class="chapter-badge">Chapter B3 of 17</div>
        <h1>Anxiolytics & Sedatives</h1>
        <div class="chapter-meta">
          <span>Benzodiazepines, buspirone, anti-dementia drugs</span>
        </div>
      </header>
      <div class="chapter-actions">
        <a href="javascript:void(0)" onclick="chapterAction('flashcards')" class="action-btn flashcard-btn">
          <svg width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><rect x="2" y="3" width="20" height="14" rx="2"/><line x1="8" y1="21" x2="16" y2="21"/><line x1="12" y1="17" x2="12" y2="21"/></svg>
          Flashcards
        </a>
        <a href="javascript:void(0)" onclick="chapterAction('quiz-fundamental', 9)" class="action-btn quiz-btn">
          <svg width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M9 11l3 3L22 4"/><path d="M21 12v7a2 2 0 01-2 2H5a2 2 0 01-2-2V5a2 2 0 012-2h11"/></svg>
          Quick Quiz: Fundamental
        </a>
        <a href="javascript:void(0)" onclick="chapterAction('advanced-learning', 9)" class="action-btn mastery-btn">
          <svg width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><polygon points="12 2 15.09 8.26 22 9.27 17 14.14 18.18 21.02 12 17.77 5.82 21.02 7 14.14 2 9.27 8.91 8.26 12 2"/></svg>
          Advanced Learning
        </a>
      </div>
      <section class="content-section">
        <h2>Overview</h2>
        <p>This chapter covers <span class="key-term">anxiolytics</span> (medications used to treat anxiety disorders), including benzodiazepines and buspirone, as well as <span class="key-term">anti-dementia medications</span>. These medication classes appear regularly on the EPPP because understanding their mechanisms, side effects, and clinical considerations is essential for psychologists collaborating with prescribers.</p>
      </section>
<section class="content-section">
        <h2>Benzodiazepines</h2>
        <p><span class="key-term">Benzodiazepines</span> are the most commonly prescribed anxiolytics. They enhance the effect of the inhibitory neurotransmitter <strong>GABA (gamma-aminobutyric acid)</strong> by binding to the GABA-A receptor complex and increasing the frequency of chloride channel opening, leading to neuronal inhibition.</p>

        <h3>Common Benzodiazepines</h3>
        <table>
          <tr><th>Generic Name</th><th>Brand Name</th><th>Duration</th><th>Notable Features</th></tr>
          <tr><td>Diazepam</td><td>Valium</td><td>Long-acting</td><td>Rapid onset; used for anxiety, seizures, muscle spasms, alcohol withdrawal; active metabolites prolong effects</td></tr>
          <tr><td>Lorazepam</td><td>Ativan</td><td>Intermediate</td><td>No active metabolites; safe in liver impairment; commonly used in acute agitation; IM administration well-absorbed</td></tr>
          <tr><td>Alprazolam</td><td>Xanax</td><td>Short-acting</td><td>Most commonly prescribed benzodiazepine; high abuse potential; significant rebound anxiety; commonly used for panic disorder</td></tr>
          <tr><td>Clonazepam</td><td>Klonopin</td><td>Long-acting</td><td>Used for panic disorder, seizures, social anxiety; longer duration reduces interdose rebound</td></tr>
          <tr><td>Chlordiazepoxide</td><td>Librium</td><td>Long-acting</td><td>Historically used for alcohol withdrawal protocols; first benzodiazepine synthesized</td></tr>
          <tr><td>Triazolam</td><td>Halcion</td><td>Ultra-short</td><td>Used as a hypnotic (sleep aid); risk of anterograde amnesia; very short half-life</td></tr>
        </table>

        <h3>Clinical Considerations</h3>
        <ul>
          <li><strong>Rapid onset of action</strong> (minutes to hours), unlike antidepressants which take weeks</li>
          <li><strong>Tolerance and dependence</strong> develop with chronic use; benzodiazepines should generally be prescribed for short-term use</li>
          <li><strong>Withdrawal</strong> can be medically dangerous (seizures, delirium); must be tapered gradually, never stopped abruptly</li>
          <li><strong>Cross-tolerance</strong> exists with alcohol and barbiturates (all act on GABA receptors)</li>
          <li>Benzodiazepines are <strong>respiratory depressants</strong>; combined with opioids or alcohol, the risk of fatal respiratory depression increases significantly</li>
          <li>Older adults are at increased risk for falls, cognitive impairment, and paradoxical reactions (agitation, disinhibition)</li>
        </ul>
        <div class="definition-box">
          <strong>Flumazenil (Romazicon)</strong>
          <p><span class="key-term">Flumazenil</span> is the specific benzodiazepine antagonist used to reverse benzodiazepine overdose. It competitively blocks the benzodiazepine binding site on the GABA-A receptor. Caution: it can precipitate seizures in patients with benzodiazepine dependence.</p>
        </div>
      </section>
<section class="content-section">
        <h2>Buspirone (BuSpar)</h2>
        <p><span class="key-term">Buspirone</span> is a non-benzodiazepine anxiolytic used primarily for <strong>generalized anxiety disorder (GAD)</strong>.</p>
        <ul>
          <li><strong>Mechanism:</strong> Partial agonist at serotonin 5-HT1A receptors; does not act on GABA receptors</li>
          <li><strong>Onset:</strong> Takes <strong>2-4 weeks</strong> to reach full effect (similar to antidepressants), making it unsuitable for acute anxiety relief</li>
          <li><strong>Advantages:</strong> No sedation, no tolerance or dependence, no withdrawal syndrome, no cross-tolerance with alcohol/benzodiazepines, no abuse potential</li>
          <li><strong>Disadvantages:</strong> Slow onset; not effective for acute anxiety or panic; patients who have previously used benzodiazepines may perceive it as ineffective due to the absence of the immediate sedating effect</li>
        </ul>
        <div class="clinical-note">
          <strong>EPPP Tip</strong>
          <p>Buspirone is a favorite EPPP topic because it differs from benzodiazepines in every key way: slow onset, no sedation, no dependence, no withdrawal, no cross-tolerance with alcohol. If a question asks about an anxiolytic that is safe for patients with a history of substance abuse, buspirone is the answer.</p>
        </div>
      </section>
<section class="content-section">
        <h2>Anti-Dementia Medications</h2>
        <p>Currently available medications for <span class="key-term">Alzheimer's disease</span> provide symptomatic relief but do not halt or reverse the underlying neurodegenerative process.</p>

        <h3>Cholinesterase Inhibitors</h3>
        <p>These drugs inhibit the enzyme <span class="key-term">acetylcholinesterase</span>, which breaks down acetylcholine, thereby increasing acetylcholine availability in the brain. They are used for mild to moderate Alzheimer's disease.</p>
        <table>
          <tr><th>Generic Name</th><th>Brand Name</th><th>Notable Features</th></tr>
          <tr><td>Donepezil</td><td>Aricept</td><td>Most commonly prescribed; once-daily dosing; approved for all stages of Alzheimer's; relatively well-tolerated</td></tr>
          <tr><td>Rivastigmine</td><td>Exelon</td><td>Available as a transdermal patch (reduces GI side effects); also inhibits butyrylcholinesterase; approved for Parkinson's disease dementia</td></tr>
          <tr><td>Galantamine</td><td>Razadyne</td><td>Also modulates nicotinic acetylcholine receptors</td></tr>
        </table>
        <p><strong>Common side effects:</strong> Nausea, diarrhea, vomiting, decreased appetite, dizziness, bradycardia (all related to increased cholinergic activity).</p>

        <h3>Memantine (Namenda)</h3>
        <ul>
          <li><strong>Mechanism:</strong> NMDA receptor antagonist; blocks excessive glutamate activity (thought to protect against excitotoxicity)</li>
          <li><strong>Uses:</strong> Moderate to severe Alzheimer's disease; often used in combination with a cholinesterase inhibitor</li>
          <li><strong>Side effects:</strong> Generally well-tolerated; dizziness, headache, constipation, confusion</li>
        </ul>
        <div class="clinical-note">
          <strong>EPPP Tip</strong>
          <p><strong>Cholinesterase inhibitors</strong> (donepezil, rivastigmine, galantamine) work by increasing acetylcholine and are used for mild to moderate Alzheimer's. <strong>Memantine</strong> is an NMDA antagonist used for moderate to severe Alzheimer's. These drugs slow symptom progression but do NOT cure or reverse the disease.</p>
        </div>
      </section>

      <section class="content-section">
        <h2>Key Takeaways for the EPPP</h2>
        <ul>
          <li><strong>Benzodiazepines</strong> enhance GABA activity; rapid onset but carry risks of dependence, tolerance, and dangerous withdrawal (seizures). Never discontinue abruptly.</li>
          <li><strong>Flumazenil</strong> is the benzodiazepine antagonist used in overdose.</li>
          <li><strong>Buspirone</strong> is a 5-HT1A partial agonist; no sedation, no dependence, no cross-tolerance with alcohol; takes 2-4 weeks to work.</li>
          <li><strong>Cholinesterase inhibitors</strong> (donepezil, rivastigmine, galantamine) increase acetylcholine and are used for mild to moderate Alzheimer's.</li>
          <li><strong>Memantine</strong> is an NMDA antagonist used for moderate to severe Alzheimer's.</li>
          <li>Anti-dementia drugs slow symptom progression but do <strong>not</strong> cure or reverse the disease.</li>
        </ul>
      </section>
      <div class="nav-buttons">
        <a href="antipsychotics.html" class="nav-btn">
          <svg viewBox="0 0 24 24" width="20" height="20" fill="none" stroke="currentColor" stroke-width="2"><path d="M15 18l-6-6 6-6"/></svg>
          <div>
            <div class="nav-btn-label">Previous</div>
            <div class="nav-btn-title">Antipsychotics</div>
          </div>
        </a>
        <a href="mood-stabilizers.html" class="nav-btn">
          <div style="text-align: right;">
            <div class="nav-btn-label">Next</div>
            <div class="nav-btn-title">Mood Stabilizers</div>
          </div>
          <svg viewBox="0 0 24 24" width="20" height="20" fill="none" stroke="currentColor" stroke-width="2"><path d="M9 18l6-6-6-6"/></svg>
        </a>
      </div>
    </main>
  </div>
  <div class="upgrade-modal-overlay" id="upgradeModal" onclick="if(event.target===this)this.classList.remove('visible')">
    <div class="upgrade-modal">
      <div class="upgrade-modal-icon"><svg width="28" height="28" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><polygon points="12 2 15.09 8.26 22 9.27 17 14.14 18.18 21.02 12 17.77 5.82 21.02 7 14.14 2 9.27 8.91 8.26 12 2"/></svg></div>
      <h3>Upgrade to Unlock</h3>
      <p>Flashcards, Quick Quizzes, and Mastery Quizzes are available on paid plans. Upgrade today to test your knowledge and track your progress.</p>
      <div class="upgrade-modal-actions">
        <button class="btn-dismiss" onclick="document.getElementById('upgradeModal').classList.remove('visible')">Maybe Later</button>
        <a href="../../index.html" class="btn-upgrade">View Plans</a>
      </div>
    </div>
  </div>
  <script>
    function chapterAction(action, domainNum) {
      var tier = 'free';
      try {
        var s = sessionStorage.getItem('passeppp_session');
        if (s) { tier = JSON.parse(s).tier || 'free'; }
      } catch(e) {}
      if (tier === 'free') {
        document.getElementById('upgradeModal').classList.add('visible');
        return;
      }
      if (action === 'flashcards') window.location.href = '../../index.html';
      else if (action === 'quiz-fundamental') window.location.href = '../../index.html';
      else if (action === 'advanced-learning') { var ch = document.querySelector('h1').textContent.trim(); window.location.href = '../../index.html'; }
    }
  </script>
</body>
</html>
